Skip to main content

      TrendLens

      Managing drug spend is a big part of keeping overall health care costs in check, and we’re here to help. TrendLens gives you a clear, quarterly view of the trends and drivers shaping pharmacy spend. It turns data into practical insights you can use to improve affordability, access and outcomes.

      Q3 | 25 Trend highlights

       

      • Illustration of a scale to represent GLP-1 weight loss drugs

        GLP-1s continue to reshape trend, bringing real promise for members and real pressure for clients.

      • Illustration of a bar chart to represent growth

        A drop in non-specialty trend drove an overall decrease.


      • Illustration of an IV to represent infusion drugs

        Top specialty trend drivers were oncology, psoriasis, Crohn’s disease, asthma and ulcerative colitis.

      Take a deep dive into what moved trend in Q3 2025 and what you can do to stay ahead.

      Download the report
      A pictogram showing a magnifying glass which represents highlighting or focusing.
      A photograph of Ed DeVaney, EVP & President of CVS Caremark, to accompany his quote.

      We’re the only ones in the supply chain whose sole purpose is to reduce the cost of prescriptions. We’re best at it and confident that we’ll continue to deliver the right drug at the right price to deliver the right clinical outcome.

      Ed DeVaney

      EVP & President, CVS Caremark

      A photograph of Ed DeVaney, EVP & President of CVS Caremark, to accompany his quote.

      Delivering exceptional member and client experiences

      Lowering costs is a team effort. With simplified pricing, flexible plan designs and smart, member‑focused utilization management, we help you take control of spend. And for members, we make benefits easy to understand and use, helping lower out‑of‑pocket costs, supporting better health outcomes and improving their overall experience. The impact speaks for itself.

       

      $4.3B

      in expected savings from 2025 formularies*

      Three children greet their father who has just arrived home from work. They’re happy and excited to see him. There’s a CVS Pharmacy box with prescriptions on the kitchen island.

      86%

      of members paid $0 for biosimilars*

      $7.26

      average out‑of‑pocket for a 30‑day supply*

      93%

      member satisfaction*

      Learn more

      See how we keep drug prices down while improving member health.

      Visit business.caremark.com
      A photograph of a business meeting in a professional setting, with a close up of an older woman leading the conversation.

      Help me stay ahead

      Contact us

      • *FOR $4.3B IN EXPECTED SAVINGS FROM 2025 FORMULARIES CLAIM: CVS Health, 2024. Client savings are determined using cumulative value over a 5-year period (upcoming year, current year and three prior years). All data sharing complies with applicable law, our information firewall and any applicable contractual limitations. Actual results may vary depending on benefit plan design, member demographics, programs implemented by the plan and other factors.

      • *FOR 86% OF MEMBERS PAID $0 FOR BIOSIMILARS SOURCE: P1017780525

      • *FOR $7.26 AVERAGE OUT-OF-POCKET FOR A 30-DAY SUPPLY SOURCE: P1016220524

      • *FOR 93% MEMBER SATISFACTION SOURCE: CVS Caremark member experience survey, 2025.